跳轉至內容
Merck
全部照片(1)

重要文件

UC160

Sigma-Aldrich

4-羟基甲苯磺丁脲

≥98% (HPLC)

同義詞:

N-(丁基氨基甲酰)-4-羟甲基苯磺酰胺

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C12H18N2O4S
CAS號碼:
分子量::
286.35
MDL號碼:
分類程式碼代碼:
12161501
PubChem物質ID:
NACRES:
NA.77
暫時無法取得訂價和供貨情況

化驗

≥98% (HPLC)

形狀

solid

顏色

white

mp

100-102 °C

溶解度

ethanol: soluble 12 mg/mL
0.1 M NaOH: soluble 4 mg/mL
H2O: insoluble

儲存溫度

2-8°C

SMILES 字串

CCCCNC(=O)NS(=O)(=O)c1ccc(CO)cc1

InChI

1S/C12H18N2O4S/c1-2-3-8-13-12(16)14-19(17,18)11-6-4-10(9-15)5-7-11/h4-7,15H,2-3,8-9H2,1H3,(H2,13,14,16)

InChI 密鑰

SJRHYONYKZIRPM-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

應用

4-羟基甲苯磺丁脲已用作标准品,用于测定从甲苯磺丁脲到4'-羟基甲苯磺丁脲的真菌生物转化[1]

包裝

无底玻璃瓶。内含物装在插入式熔锥内。

其他說明

甲苯磺丁脲的代谢物;通过 P450 酶的细胞色素 CYP2CIIC8 和 IIC9 亚家族形成。

準備報告

4-羟基甲苯磺丁脲可溶于乙醇(浓度为 12 mg/mL),也可溶于 0.1 MNaOH(浓度为 4 mg/mL)。它不溶于水。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9.
J O Miners et al.
Methods in enzymology, 272, 139-145 (1996-01-01)
Y K Leung et al.
Journal of biochemical and biophysical methods, 36(2-3), 87-94 (1998-08-26)
A simple HPLC/fluorescence method to detect hydroxytolbutamide (a major metabolite of the anti-diabetic drug tolbutamide) has been developed. The effects of nicotine and some of its metabolites on tolbutamide hydroxylation is described. An extraction procedure with diethyl ether was followed
Ji-Hong Shon et al.
Pharmacogenetics, 12(2), 111-119 (2002-03-05)
Several recent in-vitro data have revealed that CYP2C19, in addition to CYP2C9, is also involved in the 4-methylhydroxylation of tolbutamide. We evaluated the relative contribution of CYP2C9 and CYP2C19 genetic polymorphisms on the disposition of blood glucose lowering response to
Julia Kirchheiner et al.
Pharmacogenetics, 12(2), 101-109 (2002-03-05)
Tolbutamide is known to be metabolized by cytochrome P450 2C9 (CYP2C9), and the effects of the CYP2C9 amino acid polymorphisms *2 (Arg144Cys) and *3 (Ile359Leu) could be important for drug treatment with tolbutamide and for use of tolbutamide as a
D J Back et al.
British journal of pharmacology, 81(3), 557-562 (1984-03-01)
The effects of various drugs on the pharmacokinetics of tolbutamide have been examined in the rat. Phenobarbitone pretreatment caused a significant decrease in half life and area under the curve (AUC) and a significant increase in clearance and volume of

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務